Oncology clinics are often burdened with scheduling large volumes of cancer patients for chemotherapy under limited resources, such as nurses and chemotherapy chairs. Chemotherapy is a cancer treatment method that is administered orally or intravenously at an outpatient oncology clinic. Chemotherapy patients require a treatment regimen, which is a series of appointments over several weeks or months prescribed by the oncologist. The timing of these appointments is critical to the effectiveness of the chemotherapy treatment on cancer. This motivates the need for new methods for making efficient appointment schedules and for assessing clinic operation performance from both patient and management perspectives. This work uses a classic modeling approach based on systems theory to develop a discrete event system specification (DEVS) simulation model for oncology clinic operations called DEVS-CHEMO. DEVS-CHEMO is configurable to any oncology clinic and provides several capabilities for oncology clinic managers. For example, it can simulate scheduling of chemotherapy patients, clinic resources, and the arrival process of the patients to the clinic on the day of their appointment. This model simulates oncology clinic operations as patients receive chemotherapy treatments and thus allows for assessing scheduling algorithms using both patient and management perspectives. DEVS-CHEMO has been tested and validated using historical data from a real outpatient oncology clinic and the simulation results reported in this paper provide several insights regarding oncology clinic operations management.
Introduction
Outpatient oncology clinics often face the challenge of scheduling large volumes of cancer patients under limited resources, such as nurses and chemotherapy chairs. Chemotherapy is a commonly used treatment method for cancer and is often administered orally or intravenously at outpatient oncology clinics. Chemotherapy patients require a treatment regimen, which is a series of appointments over several weeks or months that is prescribed by the oncologist. The timing of the appointments and the increasing demand for chemotherapy treatment at outpatient oncology clinics motivates the need for efficient appointment schedules and clinic operations. The effectiveness of chemotherapy on cancer is strongly tied to the timing of the appointments.
Cancer costs in the USA exceeded US$124 billion in 2010 and are expected to increase 27% by 2020. 1 The demand for oncology services is projected to increase by 48% between 2005 and 2020 2 and there is a need to improve patient wait times in oncology clinics. 3 It is understood that the way oncology resources are managed has a direct impact on the quality of service to the patient in terms of wait time, pain management, and recovery time. However, increased demand for chemotherapy coupled with the complexity of the treatment regimens make managing patient service and resources in oncology clinics very challenging.
1
Chemotherapy appointment scheduling involves a complex problem setting for several reasons. For example, each patient's treatment regimen requires a series of appointments over several weeks, and for each appointment limited clinic resources (nurse, chemotherapy chair, chemotherapy drug, etc.) must be available. Also, patient appointment requests and actual patient arrivals to the clinic on the day of appointment are stochastic. Furthermore, nurse availability is also uncertain (e.g., nurse is sick), not to mention that the number of nurses can be the bottom-neck for clinics with high volumes of patients. Consequently, oncology clinic managers often find it challenging to schedule patients as well as being able to assess the impact of their scheduling decisions on overall clinic operations and performance. Therefore, modeling and simulation (M&S) provides a viable approach to addressing this aspect of the chemotherapy appointment scheduling problem. This paper considers the design, verification, and testing of a simulation model for an outpatient oncology clinic using the discrete event system specification (DEVS) formalism. 4 The simulation model, termed DEVS-CHEMO, involves modeling the scheduling process of clinic resources and chemotherapy patients, the arrival process of the patients to the clinic on the day of their appointment, and the oncology clinic operations as patients receive their chemotherapy treatment. DEVS-CHEMO is configurable and is designed to be tailored to any oncology clinic to enable clinic managers to evaluate different patient and resource scheduling algorithms using performance measures based on both patient and management perspectives.
This work uses the DEVS formalism because it allows for the modular and hierarchical construction of models and uses well-defined concepts for coupling model components. The modular construction enables the user to design and construct models independent of the simulation engine. DEVS-CHEMO is designed to be a simulation model for evaluating different appointment scheduling algorithms and implementation policies. This paper specifically focuses on how patients are scheduled and the impact of the number of available nurses on clinic performance. DEVS-CHEMO captures performance measures from both patient and management perspectives to identify scheduling policies that achieve high levels of patient service while at the same time satisfying the business objectives of the clinic.
The contributions of this paper include the following: providing a classic modeling approach based on systems theory to develop a configurable discrete event simulation model for outpatient oncology clinic operations; a simulator for assisting oncology clinic managers in determining appointment scheduling and operational policies, and assessment of clinic performance from both patient and management perspectives; and a computational study based on real clinic data that provides useful insights for oncology clinic managers on how to schedule chemotherapy appointments and determine staffing needs. DEVS-CHEMO provides an advance toward simulation models for managing oncology clinic operations with the goal of attaining higher levels of patient service in healthcare.
The rest of the paper is organized as follows: closely related work is reviewed in Section 2. A description of the outpatient oncology clinic setting is given in Section 3. The DEVS-CHEMO simulation model is presented in Section 4. This includes model abstraction, performance measures, design, and software implementation. A computational study based on a real oncology clinic is reported in Section 5. Concluding remarks and directions for future research are given in Section 6.
Closely related work
Discrete event simulation is now a well-known approach for modeling complex systems for various applications, including healthcare. In this work, we use the DEVS formalism 4, 5 to build a discrete event simulation model of oncology clinic operations. The DEVS formalism has since been extended and applied to various applications. It is based on dynamical systems theory and includes M&S of discrete time, discrete event, and continuous complex dynamical systems. It provides advantages of developing mathematically sound models that can easily run on several computer platforms. DEVSJAVA, a software implementation of DEVS, allows for developing DEVS simulations in Java. 6 The DEVS-CHEMO simulation model presented in this paper was implemented in DEVSJAVA.
Research in the area of scheduling of chemotherapy appointments has only received attention in the last decade, beginning with classification-based approaches. Some of these approaches are based on acuity-level classification, 7, 8 next-day scheduling, 9,10 and patient classification systems. 11 The concept of acuity is usually referred to as patient acuity and is commonly used in the health science literature but without specificity of definition or measurement. In general, patient acuity refers to the measure of the intensity of care required for a patient accomplished by a nurse. Studies in the literature show that patient acuity is useful for estimating nurse staffing allocations and budget determinations, is very important to patient safety, and promotes promotes equitable nurse patient assignments or nurse load balancing. 12, 13 It was not until the last few years that optimization techniques also started being applied to chemotherapy appointment scheduling.
2,14-17 Algorithms for scheduling patient appointments while considering treatment regimen specifications and infusion times to minimize patient waiting time and optimize chair utilization have been introduced. 18 Mixed-integer programming (MIP) to optimize nurse schedules on a weekly and monthly basis has been considered for a combination of full-time and part-time nurses to minimize the number of nurse shortage hours. 19 Dynamic optimization has been used in chemotherapy appointment scheduling to capture the uncertainty of realtime requests for appointments and uncertainty due to lastminute scheduling changes. 17 The work that is closely related to this paper in terms of the simulation approach is that of Pérez-Roman 20 and Pérez-Roman et al., 21 who develop a DEVS model for outpatient nuclear medicine clinics. This paper takes a dynamical systems approach to abstract and build a generic simulation model of a given oncology clinic. In addition, this work devises and tests several patient and resource scheduling algorithms within the DEVS-CHEMO simulation, which in turn allows one to generate appointment requests, simulate oncology clinic resource activities, and evaluate scheduling algorithms and operational policies.
Other discrete event simulation approaches have been used in modeling outpatient clinics in general, [22] [23] [24] [25] but is only relatively recently that they have been applied to modeling oncology clinic operations. For example, an ARENA simulation model was developed and used to analyze the layout of an outpatient oncology clinic, 26 while another ARENA model was built to compute the performance of a scheduling template by Ahmed et al. 24 Another ARENA simulation model included modeling blood exams, oncologist visits, and chemotherapy infusions, 27 and another was developed to sample expected patient wait times for the objective function of a MIP model for weekly and monthly nurse scheduling. 19 Other discrete event simulation models include a Microsoft SQL simulation model for scheduling and postponement of patient laboratory tests and infusion appointments. 18 GAMS simulation was used to build a model to evaluate scheduling policies for chemotherapy appointments. 28 This work considers a Markov decision process and dynamic programming model to schedule patient appointments within specific time windows. Next,the real outpatient oncology clinic setting is described.
Outpatient oncology clinic setting
This section describes the outpatient oncology clinic setting with a focus on the patient and resource scheduling process, patient flow in the clinic, and performance measures. The performance measures of interest include both patient and clinic management perspectives.
Patient scheduling process
When a patient is diagnosed with cancer, an oncologist usually prescribes a unique treatment regimen (e.g., see Table 1 ) based on the type and state of cancer, and the patient's current state of health. The oncologist also specifies an earliest start date to begin chemotherapy treatment so that the treatment can be successful. Delaying starting treatment (e.g., due to limited clinic resources, too many patients, and/or ineffective scheduling methods) may result in poor treatment outcomes for the patient, as the cancer may spread beyond what was expected. The start date is the number of days into the future that the patient's oncologist recommends for the first treatment to begin. As shown in Table 1 , a chemotherapy treatment regimen is a series of chemotherapy appointments and consists of the frequency of appointments (Days), drug name for each appointment (Drugs) and corresponding dosage (Dosage), the amount of time to perform the infusion (Infusion Times), and the expected relative attention the patient will require from the nurse (Acuity Levels). Treatment days specify the spacing between each appointment. In the example in Table 1 , the patient has a total of seven treatments on days 1, 2-5, 8, and 15, and rest days 6-7, 9-14, and 16-21. Infusion time is the expected time that the drug infusion is expected to take, but this is stochastic and may vary from patient to patient based on whether or not the patient gets an adverse reaction or is a ''hard stick'' (difficulty getting the drug intravenously into the patient). Patient acuity is a relative measure of the nurse's attention required by a patient during an appointment and is also subject to uncertainty.
A typical chemotherapy appointment after a patient has being diagnosed with cancer involves the following. Firstly, the treatment regimen prescribed by the oncologist is sent to a scheduler to determine the appointment schedule for each appointment in the treatment regimen, and to allocate clinic resources such as a nurse and chemotherapy chair (a special seat for the patient when receiving chemotherapy) for each appointment. All appointments in the treatment regimen need be scheduled right away to guarantee the availability of the later appointments. To maximize the effectiveness of the treatment, the appointments should be scheduled as close to the state date recommended by the oncologist as possible. Delay from the prescribed start date to the actual start date will be referred to as type I delay and can result in the cancer progressing and hence reducing the effectiveness of the chemotherapy treatment. Secondly, the patient typically has an appointment for laboratory ''blood work'' and afterward meets with the oncologist to discuss the lab results and whether or not to proceed with the scheduled chemotherapy treatment. Although this is common practice, many oncology clinics have a separate laboratory for ''blood work'' or use next-day scheduling, which allows the appointment for the chemotherapy treatment to be considered independent of the laboratory ''blood work'' appointment. Figure 1 gives a depiction of chemotherapy patient flow in an outpatient oncology clinic on the day of an appointment. When a patient arrives for a chemotherapy appointment, the patient first checks-in with a receptionist and then waits in the waiting room for an available nurse and chemotherapy chair. Once both a chair and a nurse are available, the nurse escorts the patient to the chair, orders the patient's chemotherapy drug from the pharmacy, and checks the patient's vital signs. While waiting for the drug to be prepared in the pharmacy, the nurse prepares and inserts the intravenous needle (IV) in the patient. When the chemotherapy drug is ready at the pharmacy, the patient's identity is verified and the nurse starts the patient's chemotherapy drug infusion through the IV. The entire process (escorting the patient to starting the infusion) takes about 15 minutes and the nurse is fully dedicated to a single patient during this time. Therefore, nurses can only start one patient during this 15-minute time period. Afterward, the nurse is free to either continue monitoring patients or start a new patient as the chemotherapy drug infusion can take anywhere from 30 minutes to 8 hours. Finally, stopping an infusion and discharging a patient generally takes a few minutes.
The delay a patient experiences in the waiting room after arriving at the clinic will be referred to as type II delay, while the time from when the patient is seated in the chemotherapy chair until the drug infusion begins will be referred to as the type III delay. To schedule patients and clinic resources effectively, the scheduler uses a policy, model, or algorithm to make a chemotherapy scheduling decision, which allocates a specific date, time, and set of clinic resources (chair and nurse) to each appointment in the patient's treatment regimen. Then the scheduler gives the appointment schedule to the patient and the chair and nurse resource schedules are made available for the oncology clinic operations manager.
Chemotherapy scheduling decisions are challenging for several reasons. For example, the nature of the patient flow ( Figure 1 ) in the oncology clinic requires the availability of a nurse and chair. However the availability of the nurse and chair are stochastic. Nurses sometimes get sick and do not report for work. On the other hand, a drug infusion may take longer than planned. This is because chemotherapy treatments are well-known for having nauseating side-effects and deteriorating a patient's state of health. The side-effects can occur suddenly during chemotherapy administration. Depending on the type and intensity of the treatment, nurses must pay close attention to patients in order to monitor their condition and reactions to these side-effects. It is possible for each nurse to simultaneously monitor the chemotherapy treatments of several patients at the same time. However, it is crucial that the nurses are not over-utilized, since they must be available to assist patients experiencing adverse reactions to the chemotherapy drugs. To account for this, the aforementioned concept of patient acuity, which is a relative measure of the nurse's attention required by a patient during an appointment, is used. Acuity levels are assigned a value of say 1, 2, or 3, where an acuity level of 3 (or the largest number used) represents the maximum attention required by the patient from the nurse. Each nurse can monitor several patients at once, provided that the sum of the acuity levels for all patients is less than or equal to a pre-determined maximum acuity level for that nurse.
Oncology clinic performance measures
This work aims to improve oncology clinic management by using a classic modeling approach based on systems theory to develop a simulation model for evaluating patient and resource scheduling rules/algorithms from both patient and management perspectives. Table 2 gives a summary of the patient and management performance measures used in DEVS-CHEMO. Part of patient service satisfaction in oncology clinics is to improve the patient's overall experience. The first performance measure of interest from the patient's perspective is type I delay. This performance measure is measured in days and is important because the timing of the chemotherapy treatment regimens is crucial to the patient's health status and recovery. Scheduling algorithms aim to begin the treatment regimen on or close to the start date prescribed by the patient's oncologist. Thus, type I delay captures how well the scheduling algorithm was able to accomplish this task. Type II delay and type III delays are performance measures that capture the delay that patients experience at the oncology clinic on the day of an appointment. System time is the overall time a patient spends at the clinic. Cancer patients are typically very sick and often weak; thus, minimizing these delays can improve the overall patient service experience in the oncology clinic.
In addition to providing a high quality of service to patients, oncology clinics must also operate from a business perspective. Table 2 also lists four management performance measures used in DEVS-CHEMO: patient throughput, chair utilization, and nurse utilization. These performance measures are used to assess the performance of the oncology clinic. Nurse overtime, the amount of time each nurse must work beyond normal clinic operating hours, is a performance measure that was particularly important to the oncology clinic that collaborated on this paper. Clinics with low nurse overtime can keep overhead costs down and increase employee satisfaction.
The variables that can be altered in an attempt to improve performance measures include patient appointment start times and the number of nurses available each day. Patient appointment start times depend on the scheduling algorithm being used and we later experiment with different scheduling algorithms to improve performance. We also perform a computational study of the ideal number of nurses required to achieve a certain level of performance.
DEVS-CHEMO simulation model
To derive the DEVS-CHEMO simulation model, first a description of the entities in a real oncology clinic setting is given. This is followed by model abstraction using an object-oriented approach to define DEVS atomic and coupled models that represent the different entities in the oncology clinic. Details of the DEVS-CHEMO model are given, including the system entity structure (SES) and software implementation. Finally, a description of patient and resource scheduling algorithms used in DEVS-CHEMO is given.
Entities in a real oncology clinic
The entities or objects in a typical real oncology clinic include human resources, patients, and clinic stations. Examples of these types of entities is listed in Table 3 . Human resources are individuals who are part of the The scheduler receives patient appointment requests and schedules each patient's treatment regimen based on the availability of clinic resources. The receptionist assists patients upon arrival at the clinic for an appointment. The RN performs many tasks during the patient's chemotherapy treatment, including seating the patient, ordering the drug, checking vitals, starting the drug infusion, etc. The charge nurse is considered the ''head nurse'' and oversees the clinic operations and availability of the two primary clinic resources, the RNs and chemotherapy chairs. The second type of entity is patients, which represents the patients in the oncology clinic. Each patient entity has a patient identification number, treatment regimen, and appointment schedule. The third type of entity is clinic stations. These are simply locations within the clinic where specific activities or services take place. The oncology clinic is composed of three clinic stations: waiting room, pharmacy, and chemotherapy chairs. Waiting room is the location where patients wait after check-in with the receptionist before the nurse assists them to a chemotherapy chair. Pharmacy is the location where drug orders are received from the RN and prepared for the patient by a pharmacist. Chemotherapy chairs are special seats located in rooms where patients sit to receive drug infusions.
DEVS-CHEMO model abstraction
The objects identified in the previous section will now be abstracted and modeled using DEVS. In DEVS, these objects are modeled as atomic models, coupled models, or simply entities. Table 4 gives a list of the atomic and coupled models that are abstractions of the real oncology clinic and make up DEVS-CHEMO. An object in DEVS represents a real or abstract thing with attributes and operations that define the object's behavior. Atomic models are the simplest and form the building blocks of DEVS models. Coupled models link atomic models in a hierarchical manner using couplings. Atomic and coupled models are used when the behavior, or current state and reaction to events in the system, of the object is needed in the simulation. An entity is used when the behavior of the object is not relevant to the simulation. Atomic models are used for simple objects with behavioral properties, while coupled models are used when the object has relatively more complex behavior and is composed of atomic and/or coupled models.
The atomic models are coupled in a hierarchical manner to create the coupled models resulting in EF_CHEMO at the highest level of the hierarchy. Thus DEVS-CHEMO simulation model is defined by the EF-CHEMO coupled model, which is composed of EF (experimental frame) and CHEMO (oncology clinic) coupled models connected as shown in Figure 2 . Detailed depictions of the two models are given in Figures 3 and 4 , respectively. The EF coupled model defines the environment for testing and evaluating CHEMO, the oncology clinic simulation model. As can be seen in Figure 3 , it comprises atomic models CGENR, SCHED, PGENR, and TRANSD coupled as shown in the figure. CGENR generates and sends calls to the clinic for appointment requests, while SCHED mimics the scheduling of the appointments. In turn, PGENR is responsible for generating patient arrivals to the clinic on the day of the appointment. Finally, TRANSD is responsible for computing patient and management performance measures of interest. Details of the atomic models comprising EF now follow.
The CGENR atomic model represents the oncologist identifying a new cancer patient, prescribing a unique treatment regimen, and the patient requesting a series of appointments for the prescribed treatment regimen. In DEVS-CHEMO, CGENR creates a new chemotherapy The SCHED atomic model schedules all patient appointments in the treatment regimen using a scheduling algorithm selected by the user. It has one input port and two output ports. The ''out_ApptTimes'' output port sends information to the PGENR atomic model and the ''out_Wait1Time'' output port sends information to the TRANSD atomic model. SCHED has two states, ''Idle'' and ''Scheduling.'' The model is initialized in the ''Idle'' state and a state transition to the ''Scheduling'' state occurs when the model is in the ''Idle'' state and a message ApptRequest is received at the ''in_ApptRequest'' input port. A method (function), Algorithm(), takes the information provided by the patient and performs the scheduling using the algorithm chosen by the user. Upon completion of this task (processingTime time has elapsed) and if there are no more appointment requests (schedQueue:isEmpty() = = true), the model transitions to the ''Idle'' state.
Two scheduling algorithms were implemented in SCHED, the As-Soon-As-Possible (ASAP) algorithm and the Chair and Nurse (CN) algorithm. The ASAP algorithm mimics how patients were scheduled at the oncology clinic that collaborated on this work (described in Section 5) at the time of this study. In this algorithm, patients are scheduled using only chair availability to assign a chair to each patient for each of their appointments in the treatment regimen without considering nurse availability. The algorithm finds the recommended date of the appointment, and considers each chair resource one-at-a-time until a chair with an adequate number of time slots is found. If the chairs are unavailable for the date, then all appointments are moved forward one day and the search process is performed again. In the CN algorithm patients are scheduled using both chair and nurse availability. Thus, a chair and nurse are assigned for each patient appointment. The algorithm uses the same search procedure as the ASAP to find an available chair and, once a chair is selected, the algorithm then searches for a nurse who can start the appointment and handle the additional patient acuity. The latter constraint requires that the sum of the acuity levels of all patients assigned to the nurse is less than or equal to a specified maximum acuity level. If the constraint is satisfied, then the appointment schedule is kept; otherwise, the nurse search process is resumed or another time slot is selected based on chair availability. Due to space limitations, mathematical descriptions of the algorithms are omitted.
The PGENR atomic model generates patient arrivals to the oncology clinic at their scheduled appointment date and time. PGENR has one input port and one output port. The ''in_ApptTimes'' input port receives information from the SCHED atomic model, while the ''out_PatientAppt'' output port allows for transmitting information to the RECEPT atomic model. Like CGENR, PGENR also has two states, ''Idle'' and ''Generating.'' The TRANSD atomic model captures data points from other atomic models and computes patient and management performance measures. TRANSD has six input ports and no output ports. The ''in_Wait1Time,'' ''in_Wait2Time,'' and ''in_Wait3Time'' input ports receive information from the SCHED as well as the WAITROOM and REGNURSE atomic models (described next). The ''in_WaitRoomCapacity'' input port receives information from the WAITROOM while the ''in_NurseTime'' and ''in_PatientDepart'' receive information from the REGNURSE atomic model. TRANSD has two states, ''Idle'' and ''Processing.'' The CHEMO coupled model is composed of RECEPT, WAITROOM, PHARM, CHARGENURSE, and REGNURSEi atomic models, coupled as shown in Figure 4 . CHEMO captures the daily operations of the oncology clinic as patients attend their appointments. Since an oncology clinic typically has more that one RN, CHEMO assumes that there are n RNs. Thus, we have REGNURSE1, Á Á Á, REGNURSEn, indexed by i. Details of each of the atomic models in CHEMO now follow. The RECEPT atomic model receives each patient who arrives at the oncology clinic for an appointment, directs the patient to the waiting room, and notifies the charge nurse of the patient's arrival to the clinic. RECEPT has one input port and one output port. The ''in_ApptTimes'' input port receives information from the PGENR atomic model and the ''out_PatientAppt'' output port sends information to the CHARGENURSE and WAITROOM atomic models. RECEPT has three states, ''Available,'' ''ServingPatient,, and ''Closed.'' The WAITROOM atomic model holds patients after they have left the receptionist until a REGNURSEi calls the patient to begin their chemotherapy treatment. WAITROOM has two input ports and two output ports. The ''in_ApptTimes'' input port receives information from the RECEPT atomic model and the ''in_PatientSeated'' input port receives information from the REGNURSEi. The ''out_Wait2Time'' and ''out_ WaitRoomCapacity'' output ports send information to TRANSD. RECEPT has three states, ''Open,'' ''Processing,'' and ''Closed.'' The PHARM atomic model receives drug orders from REGNURSEi, prepares the chemotherapy drugs, and notifies the REGNURSEi when the drugs are ready. PHARM has one input port and n output ports of type ''out_Drug-Ordern,'' where n is the number of RNs in the oncology clinic. The ''in_DrugOrder'' input port receives information from REGNURSE and each ''out_ DrugOrderi'' output port sends information to the corresponding REGNURSEi atomic model. PHARM has two states: ''Idle'' and ''PreparingOrder.' ' The CHARGENURSE atomic model represents the charge nurse and manages patients and clinic resources. The primary responsibility of CHARGENURSE is to assign patients who are ready for treatment to an available chemotherapy chair and RN. CHARGENURSE has two input ports and n output ports of type ''out_PatientApptn,'' where n is the number of RNs in the oncology clinic. The ''in_PatientAppt'' input port receives information from the RECEPT atomic model, while the ''in_NurseTask'' input port receives information from the REGNURSE atomic model. Each ''out_PatientAppti'' output port sends a message to the corresponding REGNURSEi atomic model to notify the nurse that a patient is available to begin their appointment. The model has three states, ''Available,'' ''ProcessingPatient,'' and ''ChairAvailable.' ' The REGNURSE atomic model is the most involved atomic model in DEVS-CHEMO. This model captures the behavior of a RN: the RN retrieves a patient from the waiting room, seats the patient in their assigned chemotherapy chair, orders drugs from the pharmacy, checks the patient's vital signs, picks up drugs from the pharmacy, starts the patient's chemotherapy drug infusion, monitors the patient, and stops the patient's chemotherapy drug infusion. REGNURSE has two input ports and six output ports. The ''in_PatientAppt'' input port receives information from the RECEPT atomic model and the ''in_DrugOrder'' input port receives information from the PHARM atomic model. The ''out_DrugOrder'' output port sends information to PHARM, the ''out_NurseTask'' output port sends information to CHARGENURSE, and the ''out_PatientSeated'' and ''out_PatientDepart'' output ports sends information to WAITROOM and TRANSD, respectively. Finally, the ''out_NurseTime'' and ''out_Wait3Time'' output ports send messages to TRANSD. REGNURSE has 12 states and its behavior is depicted using the statechart in Figure 5 . In the statechart, '' == '' denotes equality comparison and ''&'' denotes logical AND.
In Figure 5 , REGNURSEi is initialized in the ''Home'' state and a transition to the ''Available'' state occurs when the oncology clinic opens. A message received on the ''in_PatientAppt'' input causes REGNURSEi to transition to the ''CheckingWaitList'' state. In the ''CheckingWaitList'' state, if there is a patient waiting to start treatment and there is adequate time and capacity to start the patient's treatment, then REGNURSEi transitions to ''GettingPatient.'' From here, REGNURSEi transitions to a series of phases based on elapsed times, including ''SeatingPatient,'' ''OrderingDrug,'' and ''Checking Vitals.'' If REGNURSEi is in the ''CheckingVitals'' state and the drug order from the pharmacy (PHARM) is ready, then REGNURSEi transitions to ''StartingInfusion.'' Otherwise, REGNURSEi transitions to ''WaitingOnDrug'' until a message is received on the ''in_DrugOrder'' input port before transitioning to ''StartingInfusion.'' After the infStartTime has elapsed, REGNURSEi returns to ''CheckingWaitList.'' When REGNURSE is in the ''CheckingWaitList'' state and there are existing patients and the REGNURSE is unable to start a patient's treatment regimen, the model transitions to ''MonitoringPatients.'' If the model is ''MonitoringPatients,'' an input on ''in_PatientAppt'' triggers a transition back to ''CheckingWaitList''; otherwise, the nurse eventually needs to discharge a patient, transition to ''StoppingInfusion'' and then to ''CheckingWaitList.'' If REGNURSEi is in ''CheckingWaitList'' and there are no patients, no patients are waiting, and no patients were recently discharged, then the model transitions to ''Available.'' If the model is in ''CheckingWaitList'' and there are no patients and no patients are waiting but one or more patients were recently discharged, then the model transitions to ''UpdateTRANSD.'' After updating the transducer, REGNURSEi transitions to ''Available'' if the clinic is still open or transition to ''Home'' if the clinic is closed. Finally, if REGNURSEi is already in the ''Available'' state when the clinic closes, then REGNURSEi transitions to ''Home.'' Since REGNURSE is critical to the operation of DEVS-CHEMO, the DEVS mathematical description of the atomic is included in the Appendix for the interested reader.
System entity structure and software implementation
SES is used in designing simulation-based systems and shows the hierarchy associated with software models. Using SES, a DEVS modeler can visualize the relationships between atomic and coupled models. Figure 6 shows the SES for DEVS-CHEMO. In the figure, ''x_dec'' implies that model x can be decomposed into smaller models. For example, ''ef_chemo_dec'' shows that EF_CHEMO can be decomposed into EF and CHEMO. Also in the figure, ''y_multi-dec'' shows a special decomposition called multiple decomposition. This decomposition is used to represent an entity whose number in the system may vary. This means that model y can have 0, 1, 2, or more model y's. In Figure 6 , the REGNURSES model can have 0, 1, 2, or more REGNURSEs. EF_CHEMO appears at the top of the SES, which indicates that it is the highest level coupled model and can be decomposed into two other coupled models, EF and CHEMO. The EF coupled model can be decomposed into four atomic models, TRAND, PGENR, CGENR, and SCHED. The CHEMO coupled model decomposes into five atomic models, RECEPT, CHARGENURSE, REGNURSES, PHARM, and WAITROOM. The multiple decomposition node ''regnurse_multi-dec'' shows that REGNURSES can have zero or more REGNURSE atomic models. The benefit of using an SES is to provide a structural knowledge representation of the possible structures of a system that can be used in a model base, which is an organized software library of component models.
DEVS-CHEMO was designed based on the SES in Figure 6 and implemented using DEVSJAVA, 6 a Java-based M&S software using the DEVS formalism. The model was implemented using the Eclipse Standard/SDK (Kepler release version) environment. Each atomic and coupled model was tested individually using DEVSJAVA Simulation View Version (SimView) 1.2. SimView allows the modeler to visually inspect the model behavior using test inputs and starting, stopping, or slowing the simulation run to view the simulation clock and parameter values.
Application
The DEVS-CHEMO simulation model was implemented and applied to the outpatient oncology clinic at Baylor Scott & White Hospital in Temple, Texas, USA. Historical data for a 5-month period was made available to test and validate DEVS-CHEMO. This then allowed for conducting computer simulation experiments using alternative scheduling algorithms to gain insights into the clinic operations and management and to study the impact of the number of nurses on clinic performance. At the time of the study, the oncology clinic operated Monday through Friday from 8:00 a.m. to 5:00 p.m. and was closed on Saturday and Sunday. The clinic typically had one charge nurse and four to eight RNs on duty at any given time. There were 20 chemotherapy chairs in the oncology clinic, but three were reserved for emergency and special appointments. Therefore, only 17 chairs were actively used for scheduling purposes. The clinic treated about 24 patients a day on average and had at least one receptionist and scheduler available during operation hours. The historical data contained 505 patients that were scheduled over a 5-month period totaling 2070 appointments. The data also included actual appointment times and each appointment contained information on the patient's appointment date, appointment time, arrival time, IV start time, IV stop time, drug name(s), and each individual drug start and stop time(s). Data on type II and type III delays was only available as the sum of the two measures in the historical data, and is reported as type II + III delay in Table 5 . The number of chairs and number of nurses available each day was also available. Data on type I delay, resource assignments, and resource utilization were not available for analysis. A summary of the historical data statistics for a 5-month period is given in Table 5 . The table lists the performance measures and their corresponding mean, standard deviation (Stdev), and units used.
At this clinic, each day was divided into 15-minute time slots for scheduling purposes. Patient and resource scheduling was done as follows. When a patient calls the scheduler to get an appointment, the patient provides their treatment regimen and start date. The scheduler then uses the ASAP algorithm based on the availability of the 17 chemotherapy chairs to schedule the patient's appointment. RN availability is ignored in this scheduling algorithm. The scheduler begins with the recommended start date and ensures that the first appointment and all subsequent appointment dates can be accommodated by the availability of the chemotherapy chairs. If any appointment in the treatment regimen cannot be satisfied, the scheduler moves all appointments by one day and checks again. This process is repeated until all appointments in the treatment regimen are successfully scheduled. Next, the design of experiments is described.
Design of experiments
The design of experiments was aimed at understanding how patients and clinic resources should be scheduled and how the number of nurses impacts clinic performance. To address these issues, three different experiments were designed and conducted. The first experiment (Experiment 1) was aimed at testing and validating DEVS-CHEMO using historical data so as to recreate what had happened over a 5-month period. The second experiment (Experiment 2) was a comparative experiment to study the impact of using the ASAP and CN algorithms on clinic performance. Finally, the third experiment (Experiment 3) used the ASAP algorithm to assess the effect of the number of available nurses on clinic performance with a goal of determining the appropriate number of nurses for the clinic.
The performance measures listed in Table 2 were used to analyze simulation results from the patient and management perspectives. To account for the stochastic nature of several simulation parameters, 100 replications were performed for each experiment. Furthermore, clinic operations were simulated for a 5-month period based on the historical data. For each experiment, the mean, standard deviation, and 90% confidence interval for all performance measures were computed and reported. The simulations were conducted on a Dell Precision T7500 with an Intel(R) Xeon(R) dual processor running at 2.40 GHz with 12.0 GB RAM.
Even though simulation runs in DEVS-CHEMO used the chair and/or nurse assignments for scheduling purposes, due to the stochastic nature of patient arrivals and treatment duration at the clinic, it was unrealistic to rigidly apply these rules on the actual day of the appointment in the simulation. Instead, the assigned nurse and/or assigned chair were used only to schedule the appointment times for the patient. However, those assignments were not necessarily kept during the actual appointment. If the scheduling algorithm contained a nurse or chair assignment, DEVS-CHEMO first tried to use that assignment if the assigned resource was available. Otherwise, DEVS-CHEMO re-assigned the patient to the next available resource. This policy was implemented because initial experiments showed that maintaining the resource assignments resulted in high idle times for some resources, overutilization for other resources, and high levels of clinic overtime.
The stochastic nature of patient treatment duration means that when a patient has a longer treatment duration than expected, their assigned chair will still be occupied when the next patient arrives to the clinic. Although a second chair may be available for the instances where other patients had a shorter treatment duration than expected, the goal of maintaining chair and nurse assignments requires that the second chair remain empty and the next patient must continue to wait for the first patient to finish treatment and for their assigned chair to become available. Under such a rigid assignment policy, most subsequent appointments will continue to be delayed and the clinic will stay open overtime to accommodate all scheduled appointments, even though other resources may have been available for use. Table 6 lists the parameters that were set to be stochastic in the simulation with the corresponding probability distributions that provided the best fit based on the clinic historical data. In the table, the empirical distributions for number of nurses available on a given day and appointment duration were constructed using historical data. The ''empirical'' distribution for patient acuity was simply based on discussions with the clinic staff. The remaining distributions were the ones that provided the best fit based on historical data using standard statistical software. The amount of time used to schedule and allocate time for each appointment is the planned time. The planned time was obtained from the drug infusion time sheets that the clinic used for scheduling purposes. The drug infusion time sheet tells the scheduler how much time to allocate for each appointment (appointment duration), depending on the drug used. The simulation used the planned time from the drug infusion time sheet to schedule patients, but the actual appointment duration was stochastic, based on analysis results from the historical data.
The stochastic parameters and corresponding distributions listed in Table 6 were used in the simulations runs for Experiments 2 and 3. The oncology clinic was assumed to operate 9 hours each day to allow for nurse overtime. The clinic had one charge nurse, one receptionist, one scheduler, and three pharmacists in the pharmacy. The number of chemotherapy chairs was set to 17 and stopping an infusion was assumed to take 2 minutes. Even though the each patient's acuity level was stochastic, the maximum acuity level for a nurse was set at 5.
Simulation results
The simulation results for all the experiments will now be reported. The results are summarized using tables and graphs and a discussion of the results is given later in the next section.
5.2.1. Experiment 1: DEVS-CHEMO testing and validation. The first experiment was designed to test and validate DEVS-CHEMO based on historical data. This was done by simulating the actual 2070 patient appointments from the historical data. In this experiment, patients arrived at the clinic at their appointment times and historical values for the appointment duration and arrival time to IV were used in the simulation runs. The historical number of chairs and number of nurses available each day was also used. All patients were assumed to have an acuity level of 1, while the maximum acuity level for a nurse was 5. Since data type I delay, resource assignments, and resource utilization were not available in the historical data, these were assumed to be stochastic in the simulation. Thus, 100 replications were performed to account for these uncertain parameters in the simulation. In each simulation run, the charge nurse randomly assigned patients to any available RN. Consequently, the patient-nurse assignments, nurse overtime, type II + III delay, and system time values were different for each simulation run.
The results of Experiment 1 are summarized in Table 7 . The table reports for each performance measure the mean (Mean), standard deviation (Stdev), and 90% confidence interval (90% CI). The mean values for all the performance measures except nurse overtime are within 1% of the historical values reported in Table 6 . The mean nurse overtime has a deviation of about 24% from the historical mean. This is a relatively large deviation but is not surprising, since the historical mean has a relatively large standard deviation. Overall, the Experiment 1 results reproduced identical results to the historical values and thus demonstrate that DEVS-CHEMO reproduces the events in the historical data with relative accuracy.
Experiment 2: scheduling algorithms.
The next set of experiments were designed to study the comparative performance of different scheduling algorithms. The two algorithms described in Section 4.2, THE ASAP and CN algorithms, were implemented within the SCHED atomic model. Recall that the ASAP algorithm mimics how the oncology clinic scheduled patients using an as-soon-aspossible procedure based only on chair availability. The CN algorithm was implemented as an alternative and schedules patients based on both chair and nurse availability. For each algorithm, 100 replications of simulation runs were made with the stochastic data parameters set according to the probability distributions listed in Table 5 .
The results of the simulation runs for the 5-month period are summarized in Table 8 . The table lists the algorithm, performance measure, mean, standard deviation, and 90% confidence interval. Throughput is reported as the total number of appointments served as well as the daily throughput, which is the number of patients served in a single day on average. Nurse overtime is reported in two different ways: ''Nurse overtime + '' is the average nurse overtime without including zero entries, whereas ''Nurse overtime'' is the average overtime among all nurses during the 5-month period. Nurse overtime + gives average nurse overtime across all days when there was overtime. Nurse overtime + , type II delay, type III delay, and system time are also plotted in the bar graph in Figure 7 . The graph also measures the difference between the ASAP algorithm result and that of the CN algorithm for each performance. Finally, THE computer simulation time for a single simulation run was 7.0 seconds, on average.
Experiment 3
: performance versus number of nurses. The third and last experiment was designed to assess oncology clinic performance versus the number of nurses available in the clinic each day. This experiment was motivated by the fact that the daily number of nurses was said to be the most limited resource for the oncology clinic in this study. In particular, clinic management was interested in knowing how many nurses would be required to provide adequate service without compromising patient service, while assuming a 20% increase in patient appointments. The historical daily average number of nurses in the clinic was 5.6. Therefore, in this experiment the number of available nurses each day was fixed in each simulation run, assuming a 5-month period and using the ASAP and CN algorithms, respectively, to schedule the appointments. The number of nurses was varied from five to 10. Thus, six simulation runs each with 100 replications were performed. The results of this experiment are given in Table 9 . The table reports the mean for each performance measure. The average nurse utilization, nurse overtime, and system time are also plotted in the bar graph in Figure 8 . The figure shows the trends in these performance measures as the daily number of nurses is increased from five to 10.
Discussion
The results of the three computer simulation experiments using DEVS-CHEMO provide insights into how patients should be scheduled and how the number of nurses impacts clinic performance. The experiments were designed to first test and validate DEVS-CHEMO (Experiment 1) and then to assess the performance of the scheduling algorithms (Experiment 2), as well as the impact of the daily number of nurses on overall clinic performance. Replications were made for simulation runs to guard against any pathological cases, since several parameters in the simulation were stochastic. Thus, 100 replications and a 90% confidence interval were arbitrarily selected. The results of Experiment 1 show that DEVS-CHEMO can mimic oncology clinic operations and provide results that are within the relative accuracy of the historical values. This experiment was an initial step toward validating DEVS-CHEMO and was limited by the 5-month historical clinic data that was available at the time of this study. More data is needed to fully validate DEVS-CHEMO under data conditions that may be different from what was observed in that 5-month period. Two different scheduling algorithms were implemented and tested in Experiment 2. The results show that the clinic's scheduling procedure using the ASAP method, which only considers the future availability of chemotherapy chairs in scheduling a patient, actually provides better throughput performance compared to the CN algorithm. However, it has comparable performance on most of the other performance measures. Recall that the CN algorithm considers both the chair and the nurse availability. From Figure 7 it can be observed that the CN algorithm provides better performance over the ASAP algorithm for type II delay. This is the waiting time of the patient from their arrival at the clinic to the time they get attended to by a nurse. The CN algorithm provides a patient wait time of about 13 minutes, while the ASAP algorithm gives about 22 minutes on average. Consequently, the CN algorithm also provides slightly better system time. Thus, a clinic concerned about patient wait time type II should consider the CN algorithm over the ASAP algorithm. It should also be pointed out that chair utilization for this clinic is about 50% on average, while nurse utilization is about 85%.
Thus, the number of nurses at this clinic can be increased in order to reduce nurse utilization to be below 85% if desired.
The results of Experiment 3 amply demonstrate that the number of nurses available in the clinic can indeed have a significant impact on patient and clinic performance. The results reported in Table 9 show that increasing the number of nurses for a fixed level of patient demand results in decreased nurse utilization, nurse overtime, type II delay, and system time. The results also reveal ( Figure 8 ) the diminishing returns of increasing the number of nurses from five to 10. The gains are significant for up to about seven nurses for this oncology clinic. It can be seen that for from eight to 10 nurses most of the performance measure values remain almost constant. Thus, these results indicate that having seven or eight nurses each day would provide relatively better performance than having less than seven. Also, observe that Figure 8 shows that increasing the number of nurses beyond seven leads to a reduction in nurse utilization, even though the other performance measures do not show significant gains.
Conclusion
Increased demand for chemotherapy coupled with the complexity of the treatment regimens make managing patient service and limited resources in oncology clinics very challenging for several reasons. For example, chemotherapy patients require a series of appointments over several weeks or months based on their treatment regimen as prescribed by the oncologist. Furthermore, the timing of these appointments is critical to the effectiveness of the chemotherapy treatment on cancer. This work uses the DEVS formalism to derive DEVS-CHEMO, a generic simulation model for oncology clinic operations that considers both patient and management aspects. DEVS is a formal M&S framework based on dynamical systems theory and provides well-defined concepts for hierarchical and modular model construction. DEVS-CHEMO was implemented in DEVSJAVA, and tested and validated based on data for a real oncology clinic. DEVS-CHEMO provides oncology clinic managers with a model based on systems theory for analyzing operational policies within the oncology clinic.
DEVS-CHEMO allows for computing various performance measures from the patient's perspective (type I delay, type II delay, type III delay, and system time) and from the management's perspective (throughput, chair utilization, nurse utilization, and nurse overtime). Simulation results involving implementation of two scheduling algorithms, one used at the Baylor Scott & White oncology clinic (ASAP) and one that was devised in this work (CN), reveal several insights. For example, the results show that although the ASAP and CN algorithms provide similar Figure 8 . Performance versus number of nurses for the As-Soon-As-Possible algorithm.
performance for most performance measures, the CN algorithm, which considers both chair and nurse availability, reduces type II delay, that is, patients wait less to get their treatment upon arrival at the clinic. The results also reveal that the ideal number of nurses is seven when demand for oncology clinic services is increased by 20%. Future work includes extending DEVS-CHEMO to include laboratory and blood work scheduling. This will allow for determining whether or not patient appointments get rescheduled or treatments are modified based on blood work results. Finally, modeling and simulating the health status of the patient in response to treatments can be incorporated in DEVS-CHEMO. This can play a role in estimating appointment duration and patient acuity levels for each nurse.
